Back

The novel bispecific anti-NLRP3 inflammasome antibody InflamAb inhibits atherosclerosis in apolipoprotein E-deficient mice

12 April 2024 (08:30 - 14:00)
Organised by: Logo
Congress Presentation Part of: Immune modulation in atherosclerosis Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Lucie Delfos

Leiden Academic Center for Drug Research, Leiden (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Exploring PD-1+ and tissue resident memory T cells in atherosclerotic diseases
Miss K. Van Dijk (Leiden, NL)
Abstract
Presentation thumbnail
Liraglutide prevents hyperglycemia-induced senescence and proinflammatory monocyte differentiation in CD34+ hematopoietic stem cells
Doctor G. Damiano (Milan, IT)
Abstract
Presentation thumbnail
Impact of immune system humanization on atherosclerosis in dyslipidemic immunocompromised mice
Doctor F. Bonacina (Milan, IT)
Abstract
Presentation thumbnail
Leukemia inhibitory factor receptor inhibition reduces stenosis grade and total serum cholesterol levels in a mouse model for atherosclerosis
Ms E. Hemme (Leiden, NL)
Abstract

Access the full session

Session thumbnail
Immune modulation in atherosclerosis

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources